{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T23:58:35Z","timestamp":1784937515751,"version":"3.55.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82230104, 81930089, 81773318, 82404117, 82103709 and 82303999"],"award-info":[{"award-number":["82230104, 81930089, 81773318, 82404117, 82103709 and 82303999"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Cell-free DNA (cfDNA) functions in the early-detection and monitoring of autoimmune diseases including systemic lupus erythematosus and rheumatoid arthritis. However, investigations into cfDNA profiles in dermatomyositis and their potential clinical implications remain scarce.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To explore the overall landscape of cfDNA profiles in dermatomyositis and investigate potential roles in discriminating subtypes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Following informed consent, 24 treatment-na\u00efve patients diagnosed with dermatomyositis and 16 healthy controls were enrolled. We examined cfDNA concentrations, fragment distribution patterns, 5\u2019-end motif frequencies and genetic variation profiles in all participants and studied potential correlation with laboratory parameters. Moreover, intergroup differences of cfDNA profiles among patients and potential correlation between extracellular DNases levels and cfDNA were investigated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Compared to healthy controls, dermatomyositis patients exhibited elevated cfDNA concentrations, with significantly longer cfDNA fragments, primarily centered around 180\u2013360 bp; nonetheless, no correlation was witnessed between lab parameters and cfDNA levels. The A-end predominated the 5\u2019-end motif, whereas the C-end was underrepresented, contrasting with the patterns observed in healthy controls. In addition, genetic variations in several genes, including <jats:italic>PDE4DIP<\/jats:italic> and <jats:italic>BRCA2<\/jats:italic>, were commonly detected in cfDNA from dermatomyositis patients. Notably, end-motif profiles and cfDNA fragment length exhibited variations between anti-transcription intermediary factor 1-gamma positive patients with and without malignancies. However, owing to limited sample size, we failed to draw conclusions regarding extracellular DNase levels.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This study presents the first comprehensive depiction of cfDNA profiles in patients with dermatomyositis. Furthermore, cfDNA features exhibit variability across some sub-phenotypes and may serve as discriminatory indices. Finally, potential involvement of extracellular DNases in cfDNA profiles in dermatomyositis shall be further investigated.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1605121","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T05:29:48Z","timestamp":1750138188000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Cell-free DNA profiles of dermatomyositis and its potential role in discriminating phenotypes"],"prefix":"10.3389","volume":"16","author":[{"given":"Zhuang-li","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-li","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-chen","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-hong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-yong","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2013.11.005","article-title":"The clinical features, diagnosis and classification of dermatomyositis","author":"Iaccarino","year":"2014","journal-title":"J Autoimmun"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.12.074","article-title":"Dermatomyositis: A diagnostic dilemma","volume":"79","author":"Da Silva","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab625","article-title":"Identification of distinct\u00a0cytokine\/chemokine profiles in dermatomyositis with anti-transcriptional intermediary factor 1-\u03b3 antibody","volume":"61","author":"Zhao","year":"2022","journal-title":"Rheumatol (Oxford)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2303385120","article-title":"Bioinspired nanogels as cell-free DNA trapping and scavenging organelles for rheumatoid arthritis treatment","volume":"120","author":"Zhu","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00502","article-title":"Cell-free DNA as a biomarker in autoimmune rheumatic diseases","volume":"10","author":"Duvvuri","year":"2019","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/rheumatology\/keae425","article-title":"Circulating Cell-Free DNA Promotes Inflammation in Patients with Dermatomyositis with Anti-NXP2 Antibodies via the cGAS\/STING Pathway","volume":"64","author":"Wang","year":"2024","journal-title":"Rheumatol (Oxford)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16714","article-title":"Elevation of cell-free DNA in patients with clinically amyopathic dermatomyositis","volume":"50","author":"Ishino","year":"2023","journal-title":"J\u00a0Dermatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bty560","article-title":"fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"key":"B9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s12016-018-8718-8","article-title":"Antinuclear antibodies in systemic sclerosis: an update","volume":"58","author":"Stochmal","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2015.05.016","article-title":"A brief review of nucleosome structure","volume":"589","author":"Cutter","year":"2015","journal-title":"FEBS Lett"},{"key":"B11","article-title":"The role and diagnostic value of cell-free DNA in systemic lupus erythematosus","volume":"35","author":"Truszewska","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S1568-9972(02)00101-5","article-title":"Dosage and characterization of circulating DNA: present usage and possible applications in systemic autoimmune disorders","volume":"2","author":"Galeazzi","year":"2003","journal-title":"Autoimmun Rev"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.tig.2021.04.005","article-title":"The nexus of cfDNA and nuclease biology","volume":"37","author":"Han","year":"2021","journal-title":"Trends Genet"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2020.01.008","article-title":"The biology of cell-free DNA fragmentation and the roles of DNASE1, DNASE1L3, and DFFB","volume":"106","author":"Han","year":"2020","journal-title":"Am J Hum Genet"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw3616","article-title":"Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies","volume":"372","author":"Lo","year":"2021","journal-title":"Science"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1272-6","article-title":"Genome-wide cell-free DNA fragmentation in patients with cancer","volume":"570","author":"Cristiano","year":"2019","journal-title":"Nature"},{"key":"B17","doi-asserted-by":"publisher","first-page":"103166","DOI":"10.1016\/j.critrevonc.2020.103166","article-title":"The main sources of circulating cell-free DNA: Apoptosis, necrosis and active secretion","volume":"157","author":"Hu","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.cell.2016.05.034","article-title":"Digestion of chromatin in apoptotic cell microparticles prevents autoimmunity","volume":"166","author":"Sisirak","year":"2016","journal-title":"Cell"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1815031116","article-title":"Dnase1l3 deletion causes aberrations in length and end-motif frequencies in plasma DNA","volume":"116","author":"Serpas","year":"2019","journal-title":"Proc\u00a0Natl Acad Sci USA"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.3390\/ijms24021503","article-title":"Cell-free DNA fragmentomics: the\u00a0novel promising biomarker","volume":"24","author":"Qi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cell.2015.11.050","article-title":"Cell-free DNA comprises an in vivo nucleosome footprint that informs its tissues-of-origin","volume":"164","author":"Snyder","year":"2016","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12915-023-01752-6","article-title":"Circulating cell-free DNA fragmentation is a stepwise and conserved process linked to apoptosis","volume":"21","author":"Zhu","year":"2023","journal-title":"BMC Biol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1101\/gr.121541.111","article-title":"Open chromatin defined by DNaseI and FAIRE identifies regulatory elements that shape cell-type identity","volume":"21","author":"Song","year":"2011","journal-title":"Genome Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2020.09.006","article-title":"Plasma DNA profile associated with DNASE1L3 gene mutations: clinical observations, relationships to nuclease substrate preference, and in vivo correction","volume":"107","author":"Chan","year":"2020","journal-title":"Am J Hum Genet"},{"key":"B25","doi-asserted-by":"publisher","first-page":"101384","DOI":"10.1016\/j.xcrm.2023.101384","article-title":"Cell-free DNA fragmentomics and second Malignant neoplasm risk in patients with PTEN hamartoma tumor syndrome","volume":"5","author":"Liu","year":"2024","journal-title":"Cell Rep Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat4921","article-title":"Enhanced detection of circulating tumor DNA by fragment size analysis","volume":"10","author":"Mouliere","year":"2018","journal-title":"Sci Transl Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1501321112","article-title":"Circulating tumor-derived DNA is shorter than somatic DNA in plasma","volume":"112","author":"Mouliere","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-2912","article-title":"Characterization of cell-free DNA size distribution in osteosarcoma patients","volume":"29","author":"Udomruk","year":"2023","journal-title":"Clin Cancer Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2019.09.014","article-title":"Malignancy and myositis, from molecular mimicry to tumor infiltrating lymphocytes","volume":"29","author":"Selva-O\u2019Callaghan","year":"2019","journal-title":"Neuromuscul Disord"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05286-y","article-title":"The relationship between JAK2(V617F) mutation and dermatomyositis-a case report and literature review","volume":"40","author":"Xu","year":"2021","journal-title":"Clin Rheumatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1605121\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T05:29:49Z","timestamp":1750138189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1605121\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":30,"alternative-id":["10.3389\/fimmu.2025.1605121"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1605121","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]},"article-number":"1605121"}}